心血管植入物市場：按類型、最終用戶分類 - 2023-2030 年全球預測

全球心血管植入物市場預計到2023年將大幅成長至332.6億美元，年複合成長率為6.19%，預計到2030年將達到驚人的507.2億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球心血管植入物市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球心血管植入物市場規模及預測是多少？

2.在預測期內，COVID-19 對全球心血管植入物市場的抑制要素和影響有哪些？

3. 在預測期內，全球心血管植入物市場需要投資哪些產品/細分市場/應用/領域？

4.全球心血管植入物市場的競爭策略是什麼？

5. 全球心血管植入物市場的技術趨勢和法律規範是什麼？

6.全球心血管植入物市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球心血管植入物市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 健康意識的提高和心血管疾病的增加
    • 政府機構優惠報銷政策
    • 提高心血管植入物的有效性和安全性
  • 抑制因素
    • 核准流程嚴格，設備成本高
  • 機會
    • 植入物的 3D 列印以及醫用生物聚合物和生物材料的開發
    • 智慧心血管植入物的開發
  • 任務
    • 複雜的植入物設計、生物功能化和工藝開發
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通貨膨脹的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 心血管植入物市場：按類型

• 心臟再同步治療裝置
• 冠狀動脈支架
• 心臟瓣膜
• 植入式心臟整流去顫器
• 植入式心臟起搏器
• 外周支架

第7章 心血管植入物市場：按最終用戶分類

• 心臟護理中心
• 醫院
• 專科診所

第8章 美洲心血管植入物市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太心血管植入市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲心血管植入物市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 競爭情景分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可和定價

The Global Cardiovascular Implants Market is forecasted to grow significantly, with a projected USD 33.26 billion in 2023 at a CAGR of 6.19% and expected to reach a staggering USD 50.72 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cardiovascular Implants Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cardiovascular Implants Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Cardiac Resynchronization Therapy Device, Coronary Stents, Heart Valves, Implantable Cardioverter Defibrillator, Implanted Cardiac Pacemakers, and Peripheral Stents. The Implanted Cardiac Pacemakers is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Cardiac Care Centers, Hospitals, and Specialty Clinics. The Cardiac Care Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cardiovascular Implants Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cardiovascular Implants Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiovascular Implants Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiovascular Implants Market?

4. What is the competitive strategic window for opportunities in the Global Cardiovascular Implants Market?

5. What are the technology trends and regulatory frameworks in the Global Cardiovascular Implants Market?

6. What is the market share of the leading vendors in the Global Cardiovascular Implants Market?

7. What modes and strategic moves are considered suitable for entering the Global Cardiovascular Implants Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Cardiovascular Implants Market, by Type, 2022 vs 2030
• 4.3. Cardiovascular Implants Market, by End-User, 2022 vs 2030
• 4.4. Cardiovascular Implants Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing health consciousness and growing occurrences of cardiovascular disorders
    • 5.1.1.2. Favorable reimbursement policies by government agencies
    • 5.1.1.3. Improved efficacy and safety of cardiovascular implants
  • 5.1.2. Restraints
    • 5.1.2.1. Strict approval process and high cost of devices
  • 5.1.3. Opportunities
    • 5.1.3.1. 3D printing of implants and development of medical Biopolymers and biomaterials
    • 5.1.3.2. Development of smart cardiovascular implants
  • 5.1.4. Challenges
    • 5.1.4.1. Complicated implant design, biofunctionalization, and process development
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Cardiovascular Implants Market, by Type

• 6.1. Introduction
• 6.2. Cardiac Resynchronization Therapy Device
• 6.3. Coronary Stents
• 6.4. Heart Valves
• 6.5. Implantable Cardioverter Defibrillator
• 6.6. Implanted Cardiac Pacemakers
• 6.7. Peripheral Stents

7. Cardiovascular Implants Market, by End-User

• 7.1. Introduction
• 7.2. Cardiac Care Centers
• 7.3. Hospitals
• 7.4. Specialty Clinics

8. Americas Cardiovascular Implants Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cardiovascular Implants Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cardiovascular Implants Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. CARDIOVASCULAR IMPLANTS MARKET RESEARCH PROCESS
• FIGURE 2. CARDIOVASCULAR IMPLANTS MARKET SIZE, 2022 VS 2030
• FIGURE 3. CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 6. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. CARDIOVASCULAR IMPLANTS MARKET DYNAMICS
• FIGURE 8. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CARDIOVASCULAR IMPLANTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CARDIOVASCULAR IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY IMPLANTED CARDIAC PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 12. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY CARDIAC CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CARDIOVASCULAR IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM CARDIOVASCULAR IMPLANTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. CARDIOVASCULAR IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 102. CARDIOVASCULAR IMPLANTS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 103. CARDIOVASCULAR IMPLANTS MARKET LICENSE & PRICING